Skip to content

Drug interactions

Eliglustat + Zileuton

Severity: Moderate

Eliglustat and Zileuton: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eliglustat is cleared by CYP2D6 and CYP3A4, and zileuton may raise its levels through weak CYP3A4 inhibition. Higher eliglustat exposure can prolong PR, QRS and QT intervals, particularly in CYP2D6 poor metabolizers.

What this interaction means in plain words

Eliglustat and Zileuton can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eliglustat belongs to Miscellaneous; Zileuton belongs to Respiratory.

Evidence level: Low

Why it happens

Zileuton inhibition of CYP3A4-mediated eliglustat metabolism.

What to do

Check the patient's CYP2D6 phenotype and review other interacting drugs. Monitor ECG and symptoms of arrhythmia, and avoid the combination in poor or intermediate metabolizers.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eliglustat and Zileuton, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eliglustat with Zileuton?

MediHelp rates the interaction as moderate. Eliglustat and Zileuton can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Eliglustat is cleared by CYP2D6 and CYP3A4, and zileuton may raise its levels through weak CYP3A4 inhibition. Higher eliglustat exposure can prolong PR, QRS and QT intervals, particularly in CYP2D6 poor metabolizers.

How serious is the interaction between Eliglustat and Zileuton?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check the patient's CYP2D6 phenotype and review other interacting drugs. Monitor ECG and symptoms of arrhythmia, and avoid the combination in poor or intermediate metabolizers.

What other medicines interact with Zileuton?

MediHelp also lists interactions of Zileuton with, for example, Fezolinetant, Pimozide, Alosetron. The full list is on the Zileuton page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in